The Use of Heptamethine Cyanine Dyes as Drug-Conjugate Systems in the Treatment of Primary and Metastatic Brain Tumors

Effective cancer therapeutics for brain tumors must be able to cross the blood-brain barrier (BBB) to reach the tumor in adequate quantities and overcome the resistance conferred by the local tumor microenvironment. Clinically approved chemotherapeutic agents have been investigated for brain neoplas...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, Elizabeth, Choi, Peter J., Denny, William A., Jose, Jiney, Dragunow, Mike, Park, Thomas I.-H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204086/
https://www.ncbi.nlm.nih.gov/pubmed/34141613
http://dx.doi.org/10.3389/fonc.2021.654921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204086/
https://www.ncbi.nlm.nih.gov/pubmed/34141613
http://dx.doi.org/10.3389/fonc.2021.654921

Ejemplares similares